Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8750843 | Respiratory Investigation | 2017 | 6 Pages |
Abstract
Whether NTM lung disease should be treated during anti-cancer chemotherapy has not been not clarified by this study. Induction of anti-NTM therapy should be made after careful consideration, because the duration of anti-NTM treatment is long and anti-mycobacterial drugs have extensive effects on anti-cancer drugs. However, we think that anti-NTM therapy should be introduced after consideration of the worsening of symptoms and radiological findings associated with NTM lung disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Taisuke Tsuji, Kazunari Tsuyuguchi, Kazunobu Tachibana, Yohei Kimura, Takehiko Kobayashi, Shojiro Minomo, Shinji Atagi, Akihide Matsumura, Seiji Hayashi, Katsuhiro M.D., Ph.D.,